Fluorine in PDB 8ptq: Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L

Enzymatic activity of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L

All present enzymatic activity of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L:
3.1.1.23;

Protein crystallography data

The structure of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L, PDB code: 8ptq was solved by S.Butini, U.Grether, J.Benz, L.Leibrock, S.Maramai, A.Papa, G.Carullo, S.Federico, A.Grillo, B.Di Guglielmo, S.Lamponi, S.Gemma, G.Campiani, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 46.69 / 1.55
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 90.958, 126.448, 60.271, 90, 90, 90
R / Rfree (%) 19.5 / 22.6

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L (pdb code 8ptq). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L, PDB code: 8ptq:

Fluorine binding site 1 out of 1 in 8ptq

Go back to Fluorine Binding Sites List in 8ptq
Fluorine binding site 1 out of 1 in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5L within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:49.4
occ:1.00
F1 A:EJI401 0.0 49.4 1.0
C2 A:EJI401 1.3 48.7 1.0
C3 A:EJI401 2.4 48.4 1.0
C7 A:EJI401 2.4 47.8 1.0
CG A:PHE159 3.2 70.9 1.0
O A:GLY210 3.3 35.9 1.0
CD1 A:PHE159 3.4 71.7 1.0
CD2 A:PHE159 3.4 71.9 1.0
C A:GLY210 3.5 35.6 1.0
CA A:GLY210 3.5 35.8 1.0
CG A:LEU214 3.6 37.9 1.0
C4 A:EJI401 3.6 47.5 1.0
C6 A:EJI401 3.7 47.0 1.0
CB A:PHE159 3.7 69.9 1.0
CD1 A:LEU214 3.7 38.8 1.0
CE1 A:PHE159 3.8 72.2 1.0
CE2 A:PHE159 3.8 72.5 1.0
CD2 A:LEU214 3.9 39.6 1.0
CZ A:PHE159 4.0 72.1 1.0
C5 A:EJI401 4.1 46.4 1.0
N A:ILE211 4.4 34.5 1.0
O A:SER155 4.5 75.6 1.0
CD2 A:LEU205 4.6 53.9 1.0
C A:SER155 4.9 75.3 1.0
N A:GLY210 4.9 36.1 1.0
CB A:LEU214 5.0 34.3 1.0

Reference:

S.Butini, U.Grether, K.M.Jung, A.Ligresti, M.Allara, A.G.J.Postmus, S.Maramai, S.Brogi, A.Papa, G.Carullo, D.Sykes, D.Veprintsev, S.Federico, A.Grillo, B.Di Guglielmo, A.Ramunno, A.F.Stevens, D.Heer, S.Lamponi, S.Gemma, J.Benz, V.Di Marzo, M.Van Der Stelt, D.Piomelli, G.Campiani. Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. J.Med.Chem. 2024.
ISSN: ISSN 0022-2623
PubMed: 38241614
DOI: 10.1021/ACS.JMEDCHEM.3C01278
Page generated: Fri Aug 2 22:21:14 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy